Rockwell Medical (RMTI) Short-term Investments (2010 - 2026)

Rockwell Medical has reported Short-term Investments for 17 years, with the latest figure at $14.3 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 140.42% year-over-year to $14.3 million; the trailing twelve-month figure through Mar 2026 stood at $14.3 million (up 140.42% YoY), and the FY2025 full-year result was $14.3 million, up 140.51% from the prior year.
• Short-term Investments for Q1 2026 stood at $14.3 million, roughly flat from $14.3 million in the prior quarter.
• The five-year high for Short-term Investments was $14.6 million in Q3 2022, with the low at $2.0 million in Q4 2023.
• Historically, Short-term Investments has averaged $7.7 million across 5 years, with a median of $5.9 million in 2023.
• Annual changes were most pronounced in 2023 — Short-term Investments slumped 82.86% — and 2024, when it soared 204.3%.
• Rockwell Medical's Short-term Investments stood at $11.4 million in 2022, then tumbled by 82.86% to $2.0 million in 2023, then soared by 204.3% to $5.9 million in 2024, then surged by 140.51% to $14.3 million in 2025, then retreated by 0.03% to $14.3 million in 2026.
• The last three Short-term Investments figures came in at $14.3 million (Q1 2026), $14.3 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.